To Be Discontinued Tablet Endocrinology/Metabolism
Esterified Estrogens Tablet · 409 days since initial FDA posting
FDA lists Esterified Estrogens Tablet as To Be Discontinued (Pfizer Inc.).
No availability text on this FDA row.
Esterified Estrogens Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Esterified Estrogens Tablet
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Tablet
- Presentation
- Menest, Tablet, .625 mg (NDC 61570-073-01)
- Package NDC
- 61570-073-01
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jul 29, 2025
- Last Updated
- Jul 29, 2025
- Therapeutic Category
- Endocrinology/Metabolism
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Nearby, Other Esterified Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.